Wang Y, Lu J. IDH2-mutated acute myeloid leukemia in older adults: prognostic signal is not regimen selection. Comment on: "IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy". Haematologica; https://doi.org/10.3324/haematol.2026.301220 [Early view].